Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 39.39% vs -10.81% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 33.18% vs -1.94% in Mar 2024
Compare Balance Sheet Results of Brawn Biotech
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.00
10.10
-7.10
-70.30%
Share Warrants & Outstandings
Total Reserve
0.36
-1.61
1.97
122.36%
Shareholder's Funds
3.36
8.49
-5.13
-60.42%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.51
-0.02
-0.49
-2,450.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
7.71
0.00
7.71
0.00%
Long Term Provisions
0.09
0.00
0.09
0.00%
Total Non-Current Liabilities
7.29
-0.02
7.31
36,550.00%
Current Liabilities
Trade Payables
8.24
0.24
8.00
3,333.33%
Other Current Liabilities
1.01
0.21
0.80
380.95%
Short Term Borrowings
0.00
0.24
-0.24
-100.00%
Short Term Provisions
0.08
0.00
0.08
0.00%
Total Current Liabilities
9.33
0.69
8.64
1,252.17%
Total Liabilities
19.97
9.16
10.81
118.01%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.02
0.29
0.73
251.72%
Less: Accumulated Depreciation
0.56
0.16
0.40
250.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.46
0.14
0.32
228.57%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
8.66
-8.66
-100.00%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
2.01
0.04
1.97
4,925.00%
Total Non-Current Assets
2.47
8.84
-6.37
-72.06%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
10.47
0.00
10.47
0.00%
Sundry Debtors
3.41
0.23
3.18
1,382.61%
Cash and Bank
0.20
0.05
0.15
300.00%
Other Current Assets
0.20
0.04
0.16
400.00%
Short Term Loans and Advances
3.22
0.00
3.22
0.00%
Total Current Assets
17.50
0.32
17.18
5,368.75%
Net Current Assets (Including Current Investments)
8.17
-0.37
8.54
2,308.11%
Total Current Assets Excluding Current Investments
17.50
0.32
17.18
5,368.75%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
19.97
9.16
10.81
118.01%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
0.24
-0.24
-100.00%
Book Value per share (adjusted)
11.21
8.40
2.81
33.45%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 39.39% vs -10.81% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 17.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 33.18% vs -1.94% in Mar 2024






